echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > BMJ: HpV vaccination does not increase the risk of autologic neurodefunction syndrome in women.

    BMJ: HpV vaccination does not increase the risk of autologic neurodefunction syndrome in women.

    • Last Update: 2020-09-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, researchers assessed the risk of autoneural neurodefunctional disorder syndrome associated with the 4-price HPV vaccine, including chronic fatigue syndrome, complex areaal pain syndrome, and positional erect titration syndrome.
    This study, a population-based self-controlled case study, collected information from Danish female vaccination participants on autologic neurodefunction syndrome resulting from human papillomavirus vaccination, and in 2007-16, 869 female participants aged 10-44 had autologic neurodefunction syndrome.
    of the study was the difference in the incidence of autologic neurodefurction syndrome between HPV vaccination and non-vaccinated populations.
    a total of 869 patients with autologic neurodefunctional disorder syndrome were diagnosed during the follow-up year of 1058,1902 people, of whom 136 were chronic fatigue syndrome, 535 were complex regional pain syndrome and 198 were positional erect TSD syndrome.
    In the 365 days after the four-price HPV vaccination, there was no significant increase in the risk of all autologic neurodefurction syndrome (ratio 0.99) or specific syndrome risk (chronic fatigue syndrome risk ratio of 0.38; complex area pain syndrome risk ratio of 1.31; and risk of erective TPD 0.86).
    study that did not support the 4-price HPV vaccine increased the risk of autonitatic neurodefurction syndrome such as chronic fatigue syndrome, complex area pain syndrome, or positional erect titration syndrome in women.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.